239 related articles for article (PubMed ID: 25544866)
21. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
[TBL] [Abstract][Full Text] [Related]
22. Role of sodium restriction and diuretic therapy for "resistant" hypertension in chronic kidney disease.
Sinnakirouchenan R; Kotchen TA
Semin Nephrol; 2014; 34(5):514-9. PubMed ID: 25416660
[TBL] [Abstract][Full Text] [Related]
23. Hypertension in CKD: Core Curriculum 2019.
Ku E; Lee BJ; Wei J; Weir MR
Am J Kidney Dis; 2019 Jul; 74(1):120-131. PubMed ID: 30898362
[TBL] [Abstract][Full Text] [Related]
24. Thiazides in advanced chronic kidney disease: time for a randomized controlled trial.
Sinha AD; Agarwal R
Curr Opin Cardiol; 2015 Jul; 30(4):366-72. PubMed ID: 26049383
[TBL] [Abstract][Full Text] [Related]
25. Revisiting Hypertension Treatment in Patients With Chronic Kidney Disease.
Hernandez MF; Chang TI
Semin Nephrol; 2024 May; ():151514. PubMed ID: 38735770
[TBL] [Abstract][Full Text] [Related]
26. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
27. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report.
Weir MR; Lakkis JI; Jaar B; Rocco MV; Choi MJ; Kramer HJ; Ku E
Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547
[TBL] [Abstract][Full Text] [Related]
28. Olmesartan combined with renal denervation reduces blood pressure in association with sympatho-inhibitory and aldosterone-reducing effects in hypertensive mice with chronic kidney disease.
Nishihara M; Takesue K; Hirooka Y
Clin Exp Hypertens; 2019; 41(3):211-219. PubMed ID: 29694249
[TBL] [Abstract][Full Text] [Related]
29. [Arterial hypertension in patients on chronic hemodialysis].
Zogović J; Mladenović Lj
Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
[TBL] [Abstract][Full Text] [Related]
30. [Cardiovascular risk in polycystic kidney disease].
Di Lorenzo A; Stallone G; Infante B; Grandaliano G; Schena FP
G Ital Cardiol (Rome); 2015 Sep; 16(9):479-84. PubMed ID: 26418387
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of hypertension in chronic kidney disease].
Jędras M; Sawicka M
Wiad Lek; 2014; 67(3):402-4. PubMed ID: 25782198
[TBL] [Abstract][Full Text] [Related]
32. Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead.
Viazzi F; Bonino B; Cappadona F; Pontremoli R
Intern Emerg Med; 2016 Aug; 11(5):627-35. PubMed ID: 26984204
[TBL] [Abstract][Full Text] [Related]
33. Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial.
de Vries LV; Dobrowolski LC; van den Bosch JJ; Riphagen IJ; Krediet CT; Bemelman FJ; Bakker SJ; Navis G
Am J Kidney Dis; 2016 Jun; 67(6):936-44. PubMed ID: 26803690
[TBL] [Abstract][Full Text] [Related]
34. Approach and Management of Hypertension After Kidney Transplantation.
Tantisattamo E; Molnar MZ; Ho BT; Reddy UG; Dafoe DC; Ichii H; Ferrey AJ; Hanna RM; Kalantar-Zadeh K; Amin A
Front Med (Lausanne); 2020; 7():229. PubMed ID: 32613001
[TBL] [Abstract][Full Text] [Related]
35. Evaluation and pharmacologic approach to patients with resistant hypertension.
Adams M; Bellone JM; Wright BM; Rutecki GW
Postgrad Med; 2012 Jan; 124(1):74-82. PubMed ID: 22314117
[TBL] [Abstract][Full Text] [Related]
36. Physiologic evidence of renoprotection by antihypertensive therapy.
Zhou X; Frohlich ED
Curr Opin Cardiol; 2005 Jul; 20(4):290-5. PubMed ID: 15956825
[TBL] [Abstract][Full Text] [Related]
37. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
38. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
Onuigbo MA; Onuigbo NT
QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
[TBL] [Abstract][Full Text] [Related]
39. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
Chen SS; Seliger SL; Fried LF
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
[TBL] [Abstract][Full Text] [Related]
40. The double challenge of resistant hypertension and chronic kidney disease.
Rossignol P; Massy ZA; Azizi M; Bakris G; Ritz E; Covic A; Goldsmith D; Heine GH; Jager KJ; Kanbay M; Mallamaci F; Ortiz A; Vanholder R; Wiecek A; Zoccali C; London GM; Stengel B; Fouque D; ; ;
Lancet; 2015 Oct; 386(10003):1588-98. PubMed ID: 26530623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
